Kusajili – Clinical trials directory

Result of your search per sponsor: Sylentis SAU - PharmaMar Group

Woman and Man Max 99 years
Sylentis SAU - PharmaMar Group Update Il y a 4 ans

A double-masked study of SYL1001 in patients with moderate to severe dry eye disease Assessment of efficacy of SYL1001 at 11.25 mg/mL on signs and symptoms of DED

Country None
organs None
Specialty None

unknown

More information